Skip to main content
Clinical Trials/NCT01643005
NCT01643005
Completed
N/A

Pilot Phase of Couples-Based Intervention to Reduce HIV/STD Risk (Concurrency, Number of Partners, Unprotected Sex), Strengthen Relationships, and Improve Parenting Among Young Parenting Heterosexual Couples

Yale University1 site in 1 country100 target enrollmentAugust 2012
ConditionsHIV

Overview

Phase
N/A
Intervention
Not specified
Conditions
HIV
Sponsor
Yale University
Enrollment
100
Locations
1
Primary Endpoint
High risk sexual behavior
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study seeks to develop, implement, and assess an innovative 15-session couple-based intervention to be delivered in a group format to young parents that aims to strengthen relationships and reduce HIV risk. The ultimate goal of our intervention is to reduce HIV/STD risk (concurrency, number of partners, unprotected sex), strengthen relationships, and improve parenting among young parenting heterosexual couples.

Detailed Description

This study develops a couple-based HIV prevention intervention that is innovative and important because it integrates an intervention that improves sexual health, relationship functioning, and parenting skills. Our intervention will be integrated with an existing community based parenting program. By targeting high risk heterosexual couples experiencing an important life transition that increases their stress, conflict, and sexual risk, the investigators can provide maximum benefit to the men, women, and children in our communities. Using the guiding framework of Attachment Theory and the principles of Emotion Focused Therapy, the investigators will directly address issues of emotion, intimacy,and relationship functioning to create an intervention that strengthens romantic relationships and reduces HIV risk behavior. The investigators will conduct a small pilot randomized controlled trial of 50 parenting couples randomized to either the relationship strengthening HIV prevention intervention or an active control. The intervention will last 15 weeks and each session will be approximately 1.5 hours long. The investigators will assess couples at baseline, 4-months, and 8-months.

Registry
clinicaltrials.gov
Start Date
August 2012
End Date
May 13, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women's age between 14 and 25
  • Men's age 14 or older
  • Have a child that is 0-1 year old
  • In a romantic relationship with the mother/father of the baby
  • Not known to be HIV positive
  • English speaking

Exclusion Criteria

  • Child older than 1 year
  • HIV positive

Outcomes

Primary Outcomes

High risk sexual behavior

Time Frame: 8 months

Number of sexual partners, Concurrent sexual partners, Unprotected sex, Repeat pregnancy

Secondary Outcomes

  • Relationship Functioning at 4 months(4 months)
  • Relationship Dissolution at 4 months(4 months)
  • Change from Baseline in relationship based determinants at 4 months(4 months)
  • Relationship Functioning at 8 months(8 months)
  • Relationship Dissolution at 8 months(8 months)
  • Change from Baseline in relationship based determinants at 8 months(8 months)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
N/A
Couple-based Intervention on Quality of Life in HIV Male Serodiscordant CouplesQuality of LifeHivRelationship, Social
NCT06497751City University of Hong Kong100
Completed
N/A
Couple-Based Lifestyle Intervention to Prevent Type 2 DiabetesPreDiabetesPrediabetic StateOverweight and Obesity
NCT05695170University of Utah28
Completed
N/A
Duo Partnership Adherence Commitment TherapyHIV/AIDS
NCT02925949University of California, San Francisco288
Completed
N/A
Couples Health Project: Couples-based Intervention to Reduce Drug Use and HIV Transmission RiskRisk BehaviorDrug UseSex, Anal
NCT03386110Hunter College of City University of New York100
Completed
N/A
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersMalignant Female Reproductive System NeoplasmMalignant Hepatobiliary NeoplasmPartnerStage III Breast CancerStage III Cervical CancerStage III Colorectal CancerStage III Lung CancerStage III Prostate CancerStage III Skin MelanomaStage III Uterine Corpus CancerStage IIIA Breast CancerStage IIIA Cervical CancerStage IIIA Colorectal CancerStage IIIA Lung CarcinomaStage IIIA Skin MelanomaStage IIIA Uterine Corpus CancerStage IIIB Breast CancerStage IIIB Cervical CancerStage IIIB Colorectal CancerStage IIIB Lung CarcinomaStage IIIB Skin MelanomaStage IIIB Uterine Corpus CancerStage IIIC Breast CancerStage IIIC Colorectal CancerStage IIIC Skin MelanomaStage IIIC Uterine Corpus CancerStage IV Breast CancerStage IV Cervical CancerStage IV Colorectal CancerStage IV Lung CancerStage IV Prostate CancerStage IV Skin MelanomaStage IV Uterine Corpus CancerStage IVA Cervical CancerStage IVA Colorectal CancerStage IVA Uterine Corpus CancerStage IVB Cervical CancerStage IVB Colorectal CancerStage IVB Uterine Corpus Cancer
NCT03112668Rutgers, The State University of New Jersey14